reset
Close search icon

Cambridge Oncometrix

Cambridge Oncometrix develops a non-invasive prostate liquid biopsy test for men suspected of prostate cancer. The test is based on proprietary biomarkers and will identify men who will benefit from prostate biopsy and those who can safely forgo it.

Shape banner Shape banner Shape banner

Recent News

News main image

20 January 2022

New legislation will help farmers to grow more resistant, nutritious and productive crops in the UK

Read more
News main image

19 January 2022

Saving Species through genomics in megadiverse Colombia

Read more

Recent Event

News main image

Friday, 14/01/2022 00:00

John Innes Centre Friday Seminar – ‘Bacteria-phage warfare’

Read more